Arkolith/Insider Trading/PLX/Form 4

Bashan Dror

PRESIDENT AND CEO, DirectorProtalix BioTherapeutics, Inc. (PLX) · full profile →Form 4 · filed Dec 23, 2025
Net Buying
Open-Market Buys
$101K
Open-Market Sells
$0
Net Open-Market Flow
$101K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 19, 2025Buy(P)56K$1.81$101K189K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001781450-25-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML